Abstract: An apparatus for internet protocol (IP) address continuity includes a network port configured for Internet communications and communicatively coupled to an Internet gateway device including a first IP address; an integrated cellular modem configured for Internet communications, the integrated cellular modem including a second IP address; a local area network port; a switch configured for selectively switching between a first mode where the internet communications are via the network port and a second mode where the internet communications are via the integrated cellular modem; a processor; and a memory. The memory stores instructions, which, when executed by the processor, cause the apparatus to: determine network connectivity of the Internet gateway device; selectively switch to the second mode from the first mode based on the network connectivity; receive a second signal via the integrated cellular modem; and pass the first IP address to the local area network port.

Abstract: Concentric flow focusing encapsulation devices and methods for production of microencapsulated droplets of a first core material surrounded by a second shell material include assessment of non-dimensional fluid dynamic parameters that are related to the characteristics of produced droplets. The parameters are specifically related to characteristics such as homogenous or non-homogenous modes of concentric droplet breakup, density distribution of various droplet sizes, and qualities such as monodispersity of droplets produced. By identifying control parameters in specific regions, control variables may be selected to produce droplets or particles with desired qualities.

Abstract: Concentric flow focusing encapsulation devices and methods for production of microencapsulated droplets of a first core material surrounded by a second shell material include assessment of non-dimensional fluid dynamic parameters that are related to the characteristics of produced droplets. The parameters are specifically related to characteristics such as homogenous or non-homogenous modes of concentric droplet breakup, density distribution of various droplet sizes, and qualities such as monodispersity of droplets produced. By identifying control parameters in specific regions, control variables may be selected to produce droplets or particles with desired qualities.

Abstract: Provided is a method for treatment or prevention of ?-synucleinopathies in a mammalian subject, the method comprising administering a therapeutically effective amount of at least one composition to the subject, wherein the composition comprises a molecule for pharmacological modulation of galectin activity in a mammalian brain.